ifestyle Outcomes of Absolute cardiovascular risk Feedback project

Not Applicable

Recruiting

• Conditions: Cardiovascular disease; Cardiovascular - Coronary heart disease; Cardiovascular - Diseases of the vasculature and circulation including the lymphatic system

• Registration Number: ACTRN12609000660280
• Lead Sponsor: Menzies Research Institute (UTAS)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-08-04
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Absolute cardiovascular risk(ACR) of >10%
Minimum age of females = 45yrs
Minimum age for males = 55yrs

Exclusion Criteria

1. ACR <10%
2. A history of cardiovascular morbidity(myocardial infarction, stroke, peripheral vascular disease, angina, transient ischaemic attack, >50% carotid stenosis, carotid endarterectomy or stenting, coronary artery angioplasty or stenting, coronary artery bypass grafting)
3. Serious intercurrent illness likely to cause death within the next 2 years
4. Current participation in another clinical trial
5. Not literate in English
6. GP considers them unsuitable for the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To measure the decrease in the proportion of their energy coming from saturated fats by asking participants to complete the Dietary Questionnaire for Epidemiological Studies (DQESv2) - Cancer Coucil of Victoria[baseline and 1 year after intervention];Assess dietary salt intake using DQESv2[baseline and 1 year after intervention];To monitor physical activity using The Lifescripts questionnaire and using accelerometers(Actigragh GT1M) for seven consecutive days[baseline and 1 year after intervention];Urinary Sodium Excretion will be measured in a single, timed, overnight, non-fasting urine collection- not by 24 hour urine collection. Aliquots of each sample will be measured in duplicate for sodium and potassium using indirect ion selective electrodes and for creatinine by the Abbott Jaffe reaction, all in an Abbott Architect analyser. Urinary sodium will then be converted to daily excretion rates using the multipliers of 8 hour urinary excretion.[baseline and 1 year after intervention]